This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sollensys Corp. To Complete Its Acquisition Of South Korean Maker Of Touch Screen Panels

Sollensys Corp. (OTCBB:SOLS) announced today that it anticipates the completion of the acquisition of the South Korean touch screen panel manufacturer on February 15, 2013. This acquisition was entered into on September 30, 2012. The name of the South Korean company is Sollensys Corporation.

Sollensys Corp., formerly known as Health Directory, Inc., changed its name to Sollensys Corp. to provide for the continuity of the name of the South Korean company that it is acquiring.

This acquisition has now received the necessary approvals, and the auditors are completing the audits at this time. Sollensys Corp. will file an 8-K upon completing of the audits and the closing of the acquisition.

Sollensys Corporation holds numerous patents on the touch screen panel manufacturing process. Additional information will follow upon the filing of the 8-K.

See www.sollensys.com for additional information.

Safe Harbor Statement

Sections of this press release contain forward-looking statements which reflect management's best judgment based on factors currently known but involve significant risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of unanticipated events that may be unforeseen by management. Forward-looking information provided pursuant to the safe harbor established by recent securities legislation should be evaluated in the context of these events.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs